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Abstract
Background: Individuals living in malaria endemic areas generally harbour multiple parasite strains.
Multiplicity of infection (MOI) can be an indicator of immune status. However, whether this is good or bad
for the development of immunity to malaria, is still a matter of debate. This study aimed to examine the
MOI in asymptomatic children between two and ten years of age and to relate it to erythrocyte variants,
clinical attacks, transmission levels and other parasitological indexes.
Methods: Study took place in Niakhar area in Senegal, where malaria is mesoendemic and seasonal. Three
hundred and seventy two asymptomatic children were included. Sickle-cell trait, G6PD deficiency (A- and
Santamaria) and α+-thalassaemia (-α3.7 type) were determined using PCR. Multiplicity of Plasmodium
falciparum infection, i.e. number of concurrent clones, was defined by PCR-based genotyping of the
merozoite surface protein-2 (msp2), before and at the end of the malaria transmission season. The χ2-test,
ANOVA, multivariate linear regression and logistic regression statistical tests were used for data analysis.
Results: MOI was significantly higher at the end of transmission season. The majority of PCR positive
subjects had multiple infections at both time points (64% before and 87% after the transmission season).
MOI did not increase in α-thalassaemic and G6PD mutated children. The ABO system and HbAS did not
affect MOI at any time points. No association between MOI and clinical attack was observed. MOI did not
vary over age at any time points. There was a significant correlation between MOI and parasite density, as
the higher parasite counts increases the probability of having multiple infections.
Conclusion: Taken together our data revealed that α-thalassaemia may have a role in protection against
certain parasite strains. The protection against the increase in MOI after the transmission season
conferred by G6PD deficiency is probably due to clearance of the malaria parasite at early stages of
infection. The ABO system and HbAS are involved in the severity of the disease but do not affect
asymptomatic infections. MOI was not age-dependent, in the range of two to ten years, but was correlated
with parasite density. However some of these observations need to be confirmed including larger sample
size with broader age range and using other msp2 genotyping method.
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Background
Multiplicity of infection (MOI) is the number of different
Plasmodium falciparum strains co-infecting a single host. In
malaria endemic areas, MOI can be a useful indicator of
the transmission level. Data suggest that the average
number of malaria parasite strains in an individual is well
correlated to the transmission level [1,2].
MOI can also be an indicator of the immune status. In
areas with stable malaria transmission, MOI seems to
increase as immunity develops. In asymptomatic chil-
dren, MOI is suggested to reflect acquired immunity or
premunition [3], and also to influence the risk of subse-
quent malaria attacks. However, several studies have
shown an inverse association [4-6] between MOI and
malaria attacks, while others have shown a positive corre-
lation between MOI and clinical malaria [7,8]. Thus, it is
obvious that the role of MOI for the development of
immunity to malaria is still unclear.
A number of molecular epidemiological field studies per-
formed in Papua New Guinea [9], Senegal [10], Tanzania
[11], Sudan [1] and Equatorial Guinea [12] has shown
that differences in MOI are age-dependent. The age-
dependence of MOI is interpreted as a reflection of spe-
cific anti-parasite immunity [10]. The age at which effi-
cient immunity is acquired can differ according to
transmission intensity; hence, the age of peak MOI could
vary amongst different malaria endemic areas.
Erythrocyte variants have been associated with protection
against malaria disease. However, the mechanisms
behind this protection are not very well understood.
Sickle cell trait (HbAS) and α-thalassaemia protect against
severe and fatal malaria but none has effect on asympto-
matic parasitaemia (Reviewed by Williams TN [13]).
Studies on the impact of erythrocyte variants on multiplic-
ity of P. falciparum infection are limited and contradictory.
Ntoumi et al [14] showed that HbAS was associated with
high MOI in asymptomatic Gabonese individuals,
whereas, no impact of sickle cell trait on MOI was
observed in Senegal [15]. Deficiency in the X-linked glu-
cose-6-phosphate dehydrogenase (G6PD) gene reduces
the risk of developing severe malaria. The most common
G6PD deficiency in sub-Saharan Africa is G6PD A- [16],
which is believed to have been selected by the malaria par-
asite [17]. Similarly, ABO blood group antigens have been
correlated with severe pathology, where blood group O
confers protection against malaria, in contrast to blood
group A and B [18]. The impact of G6PD deficiency and
ABO blood group on multiplicity of P. falciparum infec-
tion has so far not been investigated.
The merozoite surface proteins (MSP) are involved in
erythrocyte invasion [19] and affect parasite density and
eventually severe pathology. Genotyping of msp2  is a
standard method for assessing MOI [20], as it is highly
polymorphic in length and sequence [10].
This study examined; i) the influence of erythrocyte vari-
ants on MOI; ii) the association of MOI with the risk of
developing clinical symptoms and iii) the correlation of
MOI with age, parasite density and seasonal variation, in
asymptomatic children living in a malaria mesoendemic
area in Senegal. Results of this study indicated that both α-
thalassaemia and G6PD deficiency affected the seasonal
variation of MOI. However, MOI was not influenced by
the ABO system and HbAS. MOI was not dependent on
age (in the range of two to ten years), was correlated with
parasite density, increased after the transmission season
and was not associated with the risk of clinical attack.
Methods
Study area and subjects
The study took place in two villages (Diohine and Toucar)
in the Niakhar area, 115 km south-east of Dakar, Senegal.
Malaria is mesoendemic in this area and transmission is
seasonal from September to December, with an average of
9–12 infective bites per person and year [21]. A cohort of
372 unrelated children aged from 2 to 10 years, living per-
manently in the area was included in this study.
Sample collection
Twenty microlitres of blood were collected on filter paper
in June 2002 and January 2003, i.e. before and after the
malaria transmission season. Venous blood was collected
into heparinized Vacutainer® tubes (Becton Dickinson,
Meylan, France) at initiation of study in June 2002. Para-
sitological measurements were performed from thick
blood smears (TBS) obtained by finger prick at both time
points. After staining with Giemsa, leucocytes were
counted in 30 standardized microscopic fields in order to
obtain a mean number of leucocytes per field, and para-
sites were counted on 50 fields in order to define the par-
asitaemia as the number of parasites per 100 leucocytes.
This mode of calculation allowed us to avoid under- or
over-estimations of the parasitaemia resulting from its
determination on the basis of an assumed count of white
blood cells per microliter of blood [22]. A TBS was
declared negative when no parasite was detected in 200
fields. Research was carried out in compliance with the
Helsinki Declaration. Parents of all children gave written
informed consent, and the protocol was approved by the
ethics committee of the Health Ministry of Senegal
(N°000526/MS/DERF/DER).
Clinical survey
Part of the material was used in a malaria genetic epidemi-
ology programme. In this study an active survey of
malaria attacks was conducted during the transmissionMalaria Journal 2008, 7:17 http://www.malariajournal.com/content/7/1/17
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period for a sub group of 154 children corresponding to
the youngest children from each nuclear family [23] and
this sub group was also included in present study. Axillary
temperature was measured twice a week, and a thick
blood smear was done in the case of fever (axillary tem-
perature higher than 37.5°C) or history of fever. A malaria
attack was defined as the association of fever with a para-
site density higher than 2500/μl without any other appar-
ent cause of fever. Morbidity data generated a qualitative
variable according to the absence or the presence of at
least one malaria attack during the transmission season.
During the whole study, all children had free access to the
dispensary for diagnosis and treatment and all informa-
tion was registered.
Human genotyping
Genomic DNA was extracted using an automaton system
(Auto Gen NA 2000®). ABO blood groups, sickle-cell trait,
G6PD deficiency (A- and Santamaria) and α+-halassaemia
(-α3.7 type) were already determined as previously pub-
lished [24].
Parasite genotyping
DNA was extracted from blood on filter papers. Discs of
the same size (half of the dried blood blot) were cut out
and incubated overnight in 1 ml of 0.5% saponin in phos-
phate buffered saline (PBS) at 4°C. Discs were boiled in
200 μl of 5% Chelex-100 in water for 15 minutes after
being washed 15–30 minutes in PBS at 4°C. After centrif-
ugation at 10,000 rpm for three minutes, DNA containing
supernatant was collected. Nested PCR was performed to
determine the numbers of msp2 (FC27 and 3D7) clones.
Amplifications were done in 10 μl reaction mixture con-
taining DNA template, iProof™ High-Fidelity Master Mix
(BIO-RAD Laboratories, Hercules, CA) and 500 nM of
primer pairs. A primer pair corresponding to the outer
conserved region of the polymorphic repetitive block 3 of
msp2 was used to amplify 2.5 μl of DNA extracted from fil-
ter paper. DNA was denatured at 98°C for one minute;
then PCR was performed for 30 cycles of 98°C/10 sec,
61°C/20 sec, 72°C/30 sec, with a final five-minute exten-
sion. One microliter of PCR product was reamplified in a
pair of reactions using primers specific for FC27 and IC/
3D7 allelic types of msp2, using following program: 30 sec
at 98°C; 25 cycles of 98°C/10 sec, 61°C/20 sec, 72°C/10
sec; and a final extension for five minutes. The sequences
of used primers have been presented elsewhere [25]. The
number of products, corresponding to number of infect-
ing FC27 and IC/3D7 clones, was counted after visualiza-
tion on Ethidium Bromide (EtBr) stained 2.5 and 1.5%
agarose gels, respectively.
Statistical analysis
The χ2-test was used to compare qualitative variables such
as parasite prevalence and malaria morbidity between dif-
ferent groups or time points. Analyses of positive parasite
densities were conducted after a logarithmic transforma-
tion. Univariate analyses of quantitative variables such as
log-transformed parasite density or number of clones
were performed using ANOVA. However, in case of une-
qual variances (Bartlett's Test) non-parametric statistic
was used. Furthermore, multivariate linear regression was
used to test for confounding and independent associa-
tions between age, parasite density and MOI. A logistic
regression was used to test the association between
malaria morbidity (occurrence of malaria attack), MOI
and age. P values of <0.05 were considered to indicate sta-
tistical significance. As our objective was mainly to gener-
ate hypotheses on the putative role of MOI on the
protection conferred by erythrocyte variants, we did not
apply corrections for multiple testing when we studied the
potential association between red blood cells polymor-
phisms and MOI.
All statistical analyses were performed using StatView 5.0
(SAS Institute Inc., Cary, NC) and STATA (StataCorp.
1999, Release 8.0) softwares.
Results
Parasitological indexes
A total of 372 children in the age range of 2 to 10 years
(5.0 ± 1.6) was included in this study. Parasitological
indexes are presented in Table 1. Asymptomatic P. falci-
parum prevalence was detected by microscopy in 35% of
individuals both before (June 2002) and after (January
2003) the transmission season. Parasite prevalence, as
detected by PCR, was higher in January as compared to
June, although the difference did not reach statistical sig-
nificance.
Table 1: Parasitological indexes before and after transmission 
season
June 2002 January 2003 P value
Age-range (years) 2–10 2–10
Mean age ± SD 5.0 ± 1.6 5.6 ± 1.6
Sex ratio (M/F) 1.1 (195/177) 1.1 (195/177)
Parasite prevalencea (%)
Microscopy 35 35
PCR 44 51 NS
Parasite densityb 2.9 7.6 0.01
Parasite density 25th–75th 
percentiles
0.8–11.2 1.3–33.1
MOIc (mean) 2.5 4.1 0.0001
MOI (range) 1–7 1–10
Number of subjects 372 372
a Proportion of infected individuals.
b P. falciparum density (parasites/100 leukocytes)-median, zero values 
excluded.
c Number of clones identified as msp2 alleles, excluding PCR negatives.Malaria Journal 2008, 7:17 http://www.malariajournal.com/content/7/1/17
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The median parasite density was lower before (2.9
[0.8–11.2]/100 leukocytes) than after (7.6 [1.3–33.1]/
100 leukocytes) the transmission season (rho = 0.36, P =
0.01). Interestingly, for a small group of 58 cases, infected
at both time points, no increase in parasite density was
seen after the transmission season (not listed).
Before the transmission season, parasite density decreased
significantly with age (regression coefficient = -0.36; P =
0.004) when subjects were grouped into 2, 3, 4, 5 and
6–10 years, whereas the effect of age on PD was no more
significant in January (P > 0.18).
No significant differences in the prevalence of infection,
as detected by PCR, amongst different age groups
(grouped as above) were noted at any time points.
Multiplicity of Infection
MOI has been suggested to differ in relation to transmis-
sion intensity, age, parasite density and seasonal varia-
tion. Therefore, the MOI before and after transmission
and its relationship with the above mentioned factors was
investigated in this study. The results revealed that the
MOI (defined on PCR positive samples) was significantly
higher after the transmission season (mean 4.1 [1-10]
strains in January vs 2.5 [1-7] strains in June, P < 0.0001)
(Table 1). The majority of PCR positive subjects carried
multiple strains; 64 and 87 percent in June and January,
respectively.
The distribution of msp2 allelic families was similar before
and after transmission season, with 35% (33%) of para-
sites from 3D7, 25% (24%) of parasites from FC27 and
40% (43%) of clones from both allelic families in June
(January).
There was no significant association between age and
MOI in June (P > 0.1) or in January (P > 0.7). MOI was
positively related to parasite density at both time points (P
= 0.004 in June and P < 10-3 in January). However, as age
was negatively related to PD, a multiple linear regression
including age as an explicative variable was performed.
Age remained no significant (P > 0.5) and the same pat-
tern of results was obtained at each time points consistent
with a positive association between MOI and PD (P =
0.008 in June and P < 10-3 in January).
Parasitological data in relation to erythrocyte variants
Erythrocyte variants may alter susceptibility to parasite
invasion and thus affect the multiplicity of infection. This
study revealed that the blood groups or the studied RBC
mutations did not influence the MOI at any time points
(Table 2). After the transmission season, the MOI
Table 2: Infection prevalence and MOI in subjects stratified by blood groups and haemoglobinopathies before and after the 
transmission season
June 2002 January 2003
Whole groupa n (%) nb (%) MOI; mean (range) nb (%) MOI; mean (range)
Blood group
O 193 (52) 81/193 (42) 2.6 (1 – 7) 99/193 (51) 4.1 (1–10)g***
A 100 (27) 47/100 (47) 2.6 (1 – 7) 50/100 (50) 4.0 (1 – 9)g**
B 69 (18) 34/69 (49) 2.3 (1 – 6) 32/69 (46) 4.2 (1 – 10)g*
AB 10 (3) 2/10 (20) 4.0 (1 – 7) 7/10 (70) 4.6 (2 – 8)g*
Hemoglobin
AA 319 (86) 144/319 (45) 2.5 (1 – 7) 162/319 (51) 4.0 (1–10)g***
AS 51 (14) 19/51 (37) 2.7 (1 – 5) 26/51 (51) 4.5 (1 – 10)g**
α+-thalassemiaC
Normal 234 (76) 103/234 (44) 2.3 (1 – 7) 118/234 (50) 3.9 (1–10)g***
Mutation 75 (24) 37/75 (49) 2.8 (1 – 7) 36/75 (48) 4.1 (1 – 9)
G6PD in femalesd
Normal 141 (81) 60/141 (43) 2.7 (1 – 7) 73/141 (52)f 4.4 (1 – 10)g**
Mutation 34 (19) 11/34 (32) 2.7 (1 – 4) 9/34 (26) 4.6 (1 – 10)
G6PD in malese
Normal 166 (87) 77/166 (46) 2.5 (1 – 7) 90/166 (54) 3.8 (1–10)g***
Mutation 24 (13) 14/24 (58) 1.7 (1 – 4) 14/24 (58) 3.4 (1 – 7)
a Total number of samples = 372, missing values for hemoglobin (n = 2), α+-thalassemia (n = 63) and G6PD (n = 7).
b Proportion of infected individuals to total.
c Mutation indicated in both heterozygous and homozygous state.
d G6PD mutations include G6PD A-/B, A-/A heterozygous and A-/A- homozygous genotypes.
e G6PD mutation corresponds to A- hemizygous genotype.
f Significantly less infection prevalence in G6PD mutated girls as compared to normal ones; χ2-test, P < 0.01.
g Wilcoxon signed rank test for the comparison of MOI in June and January;
* P < 0.05
** P < 0.01
*** P < 0.0001Malaria Journal 2008, 7:17 http://www.malariajournal.com/content/7/1/17
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increased significantly in all groups of individuals except
the alpha-thalassaemic and the G6PD mutated cases.
At the end of the transmission season, in G6PD mutated
girls, the parasite prevalence (P = 0.008, Figure 1A) and
density (P = 0.04, Figure 1B) were significantly reduced as
compared to the girls carrying the normal gene.
G6PD A- girls carrying the sickle cell trait (n = 9) had sig-
nificantly lower P. falciparum prevalence (P = 0.02, Figure
1A) and counts (P = 0.03, Figure 1B) as compared to sin-
gle mutated girls (AS or G6PD A-, n = 43) and girls carry-
ing neither of these genetic traits (n = 123) (Figures 1A
and 1B). Inversely, these erythrocyte variants had no effect
on parasitological data obtained for boys (Figures 2A and
2B).
Parasite prevalence (P = 0.05) and number of concurrent
clones (P = 0.05) were to borderline to be significantly
lower, in alpha-thalassaemic children with sickle cell trait
(n = 10) as compared to the others (n = 298).
Correlation between MOI and malaria morbidity
MOI has been shown to influence clinical manifestation;
hence the association between MOI and malaria attacks
was examined in present study. Seventy (45%) out of 154
children for whom the clinical survey was performed had
a malaria attack. Of children who had at least one malaria
attack, 57 and 84 percent had multiple infections in June
and January, respectively. However, no significant associ-
ation was observed between MOI and clinical presenta-
tion (OR = 1.15; IC95 = [0.55–2.41]; P > 0.7).
Discussion
Multiplicity of malaria infection is suggested to be influ-
enced by age, transmission intensity and seasonal varia-
tion [3,15,26,27]. As expected, a general higher parasite
density and MOI after the transmission season was
observed in this study.
The distribution of msp2 3D7/FC27 allelic families before
(40/40 percent) and after (43/44 percent) the transmis-
sion season was similar. These figures are very close to
those reported in Gambia [28], Papua New Guinea [9]
and Senegal [29] but differ from those observed in other
areas (differing in malaria transmission intensity) in Sen-
egal [10,30]. This suggests that heterogeneity of P. falci-
parum  infection may differ according to geographical
location, transmission intensity and season of sampling.
As has been proposed by previous studies [31,32], high
parasite densities increase the probability of detecting
concurrent clones in an individual. Consistent with this, a
positive correlation between MOI and parasite density
was observed in this study.
Whether or not MOI is influenced by RBC variants was
examined by present study. ABO blood group had no
Parasite prevalence (A) and densities (B) amongst girls carrying G6PD A- or G6PD A-/HbAS variants Figure 1
Parasite prevalence (A) and densities (B) amongst girls carrying G6PD A- or G6PD A-/HbAS variants. Parasite 
prevalence was defined as the percentage (CI 95%) of infected subjects detected by PCR. Parasite densities were compared as 
median (25th–75th percentiles) excluding zero values.
A BMalaria Journal 2008, 7:17 http://www.malariajournal.com/content/7/1/17
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impact on MOI at any time points. This probably reflects
the fact that the ABO system does not affect the parasite
densities rather the clinical outcome of the disease, where
blood group O protects against cerebral malaria [18].
Previous studies on the association between sickle cell
trait and MOI are contradictory [14,15]. No effect of HbAS
on MOI was noted in present study. This is in line with
reports by Konate et al [15] in Senegal but in contrast to
what has been shown in Gabon [14]. The reasons for these
discrepancies are probably due to differences in the trans-
mission intensity and in the ages of the study groups.
Alpha-thalassaemic red blood cells have altered mem-
brane properties [33,34], which may affect erythrocyte
invasion by merozoites [19]. MSP2 antigen is involved in
invasion [19] and is polymorphic. Hence, changes in
membrane of α-thalassaemic RBCs may interrupt inva-
sion by parsites with certain msp2 variants, and that could
eventually influence the MOI. In accordance with this, no
significant increase in the MOI, after the transmission,
was seen in the α-thalassaemic children. This suggests that
α-thalassaemic RBCs may protect against invasion by cer-
tain parasite strains. However, these data contradicts find-
ings reported by Mockenhaupt et al [35], who did not find
an influence of α-thalassaemia on the prevalence, density
and multiplicity of symptomatic P. falciparum infection. It
is now evident that α-thalassaemia does not affect parasite
density in individuals that go on to present clinical
malaria [35-37]. The reason for these discrepancies might
be due to that Mockenhaupt et al studied symptomatic
patients, while present study comprised asymptomatic
children. Differences in sample sizes of the two studies
could also be a reason for contradictory observations. In
any case these data indicate that α-thalassaemic individu-
als may be less susceptible to infection by certain parasite
strains but once they get infected they are not protected
against clinical malaria.
Similar to α-thalassaemic, G6PD mutated children did
not show a significant increase in the MOI after the trans-
mission season. This may be explained by early phagocy-
tosis of infected G6PD deficient RBCs. Cappadoro et al
[38] have shown that ring-stage infected G6PD deficient
RBCs are 2.3 times more efficiently phagocytosed than
normal iRBC. Thus, G6PD mutated individuals probably
control the parasite growth better than subjects carrying
the normal G6PD gene. This would then lead to lower
MOI as a result of lower parasite counts at the end of
transmission season. This is supported by the fact that
girls with mutated G6PD, in this study, were found to
have significantly lower parasite prevalence and density as
compared to the girls carrying the normal gene. This phe-
nomenon was reinforced in the case of girls carrying
Parasite prevalence (A) and densities (B) amongst boys carrying G6PD A- or G6PD A-/HbAS variants Figure 2
Parasite prevalence (A) and densities (B) amongst boys carrying G6PD A- or G6PD A-/HbAS variants. Parasite 
prevalence was defined as the percentage (CI 95%) of infected subjects detected by PCR. Parasite densities were compared as 
median (25th–75th percentiles) excluding zero values.
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G6PD A- and HbAS combined erythrocyte defects,
whereas HbAS alone was not found to influence MOI over
the transmission season. No similar observation could be
made for boys, for whom the G6PD A- carriage at the
hemizygous status is assuredly responsible for enzyme
deficiency: the small sample size of the groups of erythro-
cyte variant (considered alone or in combination) carri-
ers, could have generated this absence of divergent
parasite data between groups of males.
Previous studies regarding the variation of MOI over age
have suggested that the influence of age on the multiplic-
ity of infection is highly affected by endemicity of malaria
[1,9-11]. This is probably a reflection of the development
of anti-parasite specific immunity [10]. Thus, in holo- or
hyperendemic area, immunity develops faster and at
younger age than in areas with less intense transmission
[39]. Studies have shown an age-dependent MOI in a vil-
lage with intense perennial malaria transmission but not
in areas where malaria is mesoendemic [15,29]. In line
with this, here we showed that MOI is not influenced by
age, at least not in the age range of 2 to 10 years. However,
the lack of correlation between MOI and age in present
study needs to be confirmed in a study population with
broader age range.
Reports regarding the relation of MOI and malaria mor-
bidity are contradictory. A number of studies has sug-
gested that high MOI may confer protection from
subsequent clinical malaria [4-6]. A few studies also have
associated malaria morbidity with high MOI [7,8]. In con-
trast with those, no correlation between MOI and the risk
of clinical presentation was noted in this study. This con-
tradiction may be in part due to variable genotyping pro-
tocols, differing in sensitivity and accuracy, used in
different laboratories [15,32,40,41]. In this study, sam-
pling was done only at two time points and MOI was not
determined at the time of clinical presentation. This might
be another possible reason for the lack of correlation
between MOI and development of clinical malaria, noted
in the present study. Moreover, this result underlines the
fact that parasite characteristics are certainly not the only
ones involved in malaria morbidity. Host characteristics
such as genetic polymorphisms, or transmission intensity
could also play a key role.
However, to be able to compare findings by different stud-
ies on diversity of P. falciparum infection in relation to
other parasitological indexes and/or host factors, per-
formed in different areas, methodology used by these
studies should be taken into consideration.
The genotyping results generated by PCR may differ
between different laboratories because of applying varia-
ble reagents and protocols or even handling [32]. In addi-
tion, the PCR used in this study to determine diversity of
parasite population do not discriminate between virulent
and avirulent strains. This could perhaps be a general
explanation for some of our observations here such as the
lack of association between MOI and malaria morbidity,
or the variable effects of erythrocyte variants on parasite
diversity and clinical pattern of the disease.
Conclusion
In summary, results of this study suggest that; α-thalassae-
mia may protect against infection by certain P. falciparum
strains, the protection conferred by G6PD deficiency is
probably through clearance of the malaria parasite at early
stages of infection, and that the ABO system and HbAS do
not affect asymptomatic infection. These data also
revealed that the multiplicity of P. falciparum infection in
asymptomatic children living in a mesoendemic area was
correlated with parasite density but not age, in the range
between two to ten years. MOI did not influence the risk
of clinical attack. However, to be able to draw a firm con-
clusion, this needs to be repeated and confirmed by others
and/or using other methodology. Larger sample size and
broader age range are also required to confirm observa-
tions by this study.
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